Molecularly defined extraintestinal pathogenic Escherichia coli status predicts virulence in a murine sepsis model better than does virotype, individual virulence genes, or clonal subset among E. coli ST131 isolates

References

• Nicolas-Chanoine M-H-H, Bertrand X, Madec J-Y-Y. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev. 2014;27:543–574.
   PubMed Web of Science ®Google Scholar
• Price LB, Johnson JR, Aziz M, et al. The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. MBio. 2013;4:e00377–13.
   PubMed Web of Science ®Google Scholar
• Petty NK, Ben Zakour NL, Stanton-Cook M, et al. Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci U S A. 2014;111:5694–5699.
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Pitout JDD, Gomi R, et al. Global Escherichia coli sequence type 131 clade with blaCTX-M-27 gene. Emerg Infect Dis. 2016;22:1900–1907.
   PubMed Web of Science ®Google Scholar
• Tchesnokova V, Riddell K, Scholes D, et al. The uropathogenic Escherichia coli subclone ST131-H30 is responsible for most antibiotic prescription errors at an urgent care clinic. Clin Infect Dis. 2019;68:781–787.
   Web of Science ®Google Scholar
• Can F, Azap OK, Seref C, et al. Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections. Clin Infect Dis. 2015;60:523–527.
   PubMed Web of Science ®Google Scholar
• Alghoribi MF, Gibreel TM, Dodgson AR, et al. Galleria mellonella infection model demonstrates high lethality of ST69 and ST127 uropathogenic E.coli. PLoS One. 2014;9:e101547.
   PubMed Web of Science ®Google Scholar
• Mora A, Dahbi G, López C, et al. Virulence patterns in a murine sepsis model of ST131 Escherichia coli clinical isolates belonging to serotypes O25b: h4and O16: h5are associated to specific virotypes. PLoS One. 2014;9:e87025.
   PubMed Web of Science ®Google Scholar
• Johnson JR, Porter S, Johnston B, et al. Host characteristics and bacterial traits predict experimental virulence for Escherichia coli bloodstream isolates from patients with urosepsis. Open Forum Infect Dis. 2015;2:ofv083.
   PubMed Web of Science ®Google Scholar
• Ciesielczuk H, Betts J, Phee L, et al. Comparative virulence of urinary and bloodstream isolates of extra-intestinal pathogenic Escherichia coli in a Galleria mellonella model. Virulence. 2015;6:145–151.
   PubMed Web of Science ®Google Scholar
• Blanco J, Mora A, Mamani R, et al. Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b: H4-B2-ST131:bacterial, epidemiological, and clinical characteristics. J Clin Microbiol. 2013;51:3358–3367.
   PubMed Web of Science ®Google Scholar
• Dahbi G, Mora A, Mamani R, et al. Molecular epidemiology and virulence of Escherichia coli O16: H5-ST131:comparison with H30 and H30-Rx subclones of O25b:H4-ST131. Int J Med Microbiol. 2014;304:1247–1257.
   PubMed Web of Science ®Google Scholar
• Merino I, Porter SB, Johnston BD, et al.; ITUBRAS-GEIH group. Virulence genes and subclone status as markers of experimental virulence in a murine sepsis model among Escherichia coli sequence type 131 clinical isolates from Spain. PLoS One. 2017;12:e0188838.
   PubMed Web of Science ®Google Scholar
• Johnson JR, Porter SB, Zhanel G, et al. Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect Immun. 2012;80:1554–1562.
   PubMed Web of Science ®Google Scholar
• Johnson JR, Clermont O, Menard M, et al. Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source. J Infect Dis. 2006;194:1141–1150.
   PubMed Web of Science ®Google Scholar
• Sannes MR, Kuskowski MA, Owens K, et al. Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects. J Infect Dis. 2004;190:2121–2128.
   PubMed Web of Science ®Google Scholar
• Sannes MR, Kuskowski MA, Johnson JR. Antimicrobial resistance of Escherichia coli strains isolated from urine of women with cystitis or pyelonephritis and feces of dogs and healthy humans. J Am Vet Med Assoc. 2004;225:368–373.
   PubMed Web of Science ®Google Scholar
• Johnson JR, Menard M, Johnston B, et al. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother. 2009;53:2733–2739.
   PubMed Web of Science ®Google Scholar
• Colpan A, Johnston B, Porter S, et al. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis. 2013;57:1256–1265.
   PubMed Web of Science ®Google Scholar
• Monstein H-J, Ostholm-Balkhed A, Nilsson MV, et al. Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX-M genes in Enterobacteriaceae. APMIS. 2007;115:1400–1408.
   PubMed Web of Science ®Google Scholar
• Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. J Antimicrob Chemother. 2006;57:154–155.
   PubMed Web of Science ®Google Scholar
• Carattoli A, García-Fernández A, Varesi P, et al. Molecular epidemiology of Escherichia coli producing extended-spectrum beta-lactamases isolated in Rome, Italy. J Clin Microbiol. 2008;46:103–108.
   PubMed Web of Science ®Google Scholar
• Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-third informational supplement. M100-S23. Wayne, PA: USACLSI; 2013.
   Google Scholar
• Johnson JR, Murray AC, Gajewski A, et al. Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob Agents Chemother. 2003;47:2161–2168.
   PubMed Web of Science ®Google Scholar
• Spurbeck RR, Dinh PC, Walk ST, et al. Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tract. Infect Immun. 2012;80:4115–4122.
   PubMed Web of Science ®Google Scholar
• Picard B, Garcia JS, Gouriou S, et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun. 1999;67:546–553.
   PubMed Web of Science ®Google Scholar
• Clermont O, Lavollay M, Vimont S, et al. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother. 2008;61:1024–1028.
   PubMed Web of Science ®Google Scholar
• de Toro M, Fernández J, García V, et al. Whole genome sequencing, molecular typing and in vivo virulence of OXA-48-producing Escherichia coli isolates including ST131 H30-Rx, H22 and H41 subclones. Sci Rep. 2017;7:12103.
   PubMed Web of Science ®Google Scholar
• Buckles EL, Wang X, Lane MC, et al. Role of the K2 capsule in Escherichia coli urinary tract infection and serum resistance. J Infect Dis. 2009;199:1689–1697.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Ulett GC, Totsika M, et al. Role of capsule and O antigen in the virulence of uropathogenic Escherichia coli. PLoS One. 2014;9:e94786.
   PubMed Web of Science ®Google Scholar
• Peirano G, Van Der Bij AK, Freeman JL, et al. Characteristics of Escherichia coli sequence type 131 Isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage. Antimicrob Agents Chemother. 2014;58:3762–3767.
   PubMed Web of Science ®Google Scholar
• Olesen B, Frimodt-Møller J, Leihof RF, et al. Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012. Antimicrob Agents Chemother. 2014;58:6886–6895.
   PubMed Web of Science ®Google Scholar